This tool can be used to calculate the rate of rise of PSA, expressed as the velocity in nanograms/ml/year, or the PSA doubling time, in months or years.
It is not a separate blood test that a man needs to have. is suspicious for the presence of cancer, and biopsy is recommended.
Rather, it is the change in PSA levels over time. The NCCN states in its guidelines, “For men with PSA <4 ng/ml, data suggest that a PSA velocity of≥0.35 ng/ml/y is suspicious for the possible presence of life-threatening cancer …
It is used as a tool to help determine a man's risk of having a positive biopsy for prostate cancer if he has a “normal” value.
Despite earlier findings, recent research suggests that the rate of increase of PSA (e.g. >0.35 ng/mL/yr, the 'PSA velocity') is not a more specific marker for prostate cancer than the serum level of PSA. Physicians fine-tune PSA velocity measurements to improve cancer detection Factors like age, PSA history and the presence of prostatitis are adding more relevance to PSA velocity measurements. The authors found “found no evidence to support the recommendation that men with high PSA velocity should be biopsied in the absence of other indications; this measure should not be included in practice guidelines.”[i] Journalist Jennifer Goodwin Let's say you have the following PSA values over time: January 2008: 1.4 ng/ml January 2009: 1.9 ng/ml January 2010: 1.9 ng/ml January 2011: 3.1 ng/ml April 2011: 3.6 ng/ml Then what is your PSA…
However, the PSA rate of rise may have value in prostate cancer prognosis.
The prostate-specific antigen (PSA) velocity is not a separate test.
Prostate Cancer Nomograms: PSA Doubling Time. The NCCN 2004 guidelines make the following statement: "PSA Velocity: For men with PSA < 10.0 ng/mL, data suggest that a PSA velocity of 0.75 ng/mL/yr. Consequently, both of these causes may confuse the interpretation of PSA velocity measurements. The complete guidelines and associated documentation PSA velocity is an important concept. PSA-based screening is the usual method of screening and has been studied in several large trials. Adapted from the NCI Cancer Bulletin.. A rapid increase in prostate-specific antigen (PSA) levels is not grounds for automatically recommending a prostate biopsy, according to a study published online February 24, 2011, in the Journal of the National Cancer Institute.. PSA velocity (PSAV) is simply a measure of how fast a man's PSA score rises from one test to the next over a period of time. Basically, PSA velocity is the rate at which your PSA level increases from year to year.
The most important values to enter are the date/PSA value for each PSA measured over the last 12 months. Short Form Summary: Clinical practice guidelines for PSA testing and early management of test-detected prostate cancer. Council Australia PSA Testing Guidelines Expert Advisory Panel. The rate of change in PSA levels, referred to as PSA velocity, has been studied as a marker for the presence of prostate cancer. A PSA velocity of lower than 0.75ng/mL/y has traditionally been used to prompt a prostate biopsy. Although new screening methods are being developed (such as single- and adjusted-threshold testing and PSA velocity and doubling time), evidence is insufficient to support one method of PSA-based screening over another. By: Dan Sperling, MD A 2011 study from a Memorial Sloan-Kettering (NY) team drew enough attention to make the news services. 5.1.1 Guidelines for screening and early detection 20 5.2 Clinical diagnosis 20 5.2.1 Digital rectal examination 21 5.2.2 Prostate-specific antigen 21 5.2.2.1 PSA density 21 5.2.2.2 PSA velocity and doubling time 21 5.2.2.3 Free/total PSA ratio 21 5.2.2.4 Prostate Health Index … Prostate Cancer Foundation of Australia and Cancer Council Australia, Sydney (2016). PSA velocity. PSA velocity has been suggested as a means to increase the diagnostic accuracy of PSA testing; PSA velocity is known to be higher in prostate cancer than in benign prostatic disease, but thresholds remain controversial. What is PSA Velocity? It is logical to use PSA velocity to aid decisions regarding biopsy in men with raised PSA …